Please assess the completion status of the following clinical trial:

Trial Title: Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients (either newly diagnosed, or relapsing) with peritoneal carcinomatosis from histo-pathologically proven colorectal carcinoma who are candidate for open surgery,~* Informed consent form signed.~Exclusion Criteria:~* Age less than18 years old.~* Inability to give informed consent.~* History of allergy or hypersensitivity against the investigational product (its active substance or ingredients), to iodine or to shellfish.~* Apparent hyperthyroidism, autonomous thyroid adenoma, unifocal, multifocal or disseminated autonomy of the thyroid gland.~* Documented coronary disease.~* Advanced renal impairment (creatinine \> 1,5mg/dl).~* During the 2 weeks before the enrolment, concurrent medication which reduces or increases the extinction of ICG (i.e. anticonvulsants, haloperidol and Heparin).~* Pregnancy, breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Indocyanine Green (Type: EXPERIMENTAL): Intravenous injection of 0.25 mg/kg Indocyanine Green in patients with peritoneal carcinomatosis from colorectal cancer before the surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).